Trader consensus on Polymarket prices "No" at 84.5% for a new COVID variant of concern before 2027, reflecting robust population immunity from vaccines and prior infections that has kept SARS-CoV-2 evolution in check without severe threats. The recent emergence of highly mutated BA.3.2 "Cicada" subvariant—spreading across 31 U.S. states and 20+ countries since late March—has drawn scrutiny from WHO and CDC genomic surveillance, but early data shows only modest transmissibility gains, no elevated severity, and sustained vaccine protection against hospitalization. Absent evidence of widespread immune escape or deadlier outcomes, authorities like ECDC have not upgraded it to variant of concern status, reinforcing trader confidence in the status quo through 2026 amid declining case waves.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · GüncellendiEvet
$233,739 Hac.
$233,739 Hac.
Evet
$233,739 Hac.
$233,739 Hac.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Piyasa Açıldı: Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...Trader consensus on Polymarket prices "No" at 84.5% for a new COVID variant of concern before 2027, reflecting robust population immunity from vaccines and prior infections that has kept SARS-CoV-2 evolution in check without severe threats. The recent emergence of highly mutated BA.3.2 "Cicada" subvariant—spreading across 31 U.S. states and 20+ countries since late March—has drawn scrutiny from WHO and CDC genomic surveillance, but early data shows only modest transmissibility gains, no elevated severity, and sustained vaccine protection against hospitalization. Absent evidence of widespread immune escape or deadlier outcomes, authorities like ECDC have not upgraded it to variant of concern status, reinforcing trader confidence in the status quo through 2026 amid declining case waves.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · Güncellendi
Harici bağlantılara dikkat edin.
Harici bağlantılara dikkat edin.
Sıkça Sorulan Sorular